Latest News about Jazz
Recent news which mentions Jazz
With Access To $20 Million In Financing, 1606 Corp Is Eyeing CBD Business Acquisitions As It Embarks On An Aggressive Growth Path
March 08, 2023
From Benzinga
From Benzinga
Why Cannabis Is Recession-Resistant & Turning Challenges Into Opportunities, Industry Expert Explains
March 02, 2023
From Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
From Benzinga
Cannabis-Based Medicine As A Potential Treatment For Psychosis, An Oxford University Study Says
February 17, 2023
Tickers
JAZZ
From Benzinga
2 Cannabis Stocks That Could Make You Richer
February 09, 2023
From Motley Fool
CBD-Based Life-Changing Drug For Tuberous Sclerosis Patients, Epidiolex, Now Available Via England's NHS
February 02, 2023
Tickers
JAZZ
From Benzinga
Bob Holz New Video with Darryl Jones of the Rolling Stones, Concert, Album and Endorsement
January 31, 2023
Tickers
JAZZ
From PRLog
3 Cannabis Stocks With Double-Digit Percentage Revenue Growth
January 30, 2023
From Motley Fool
The Ultimate Growth Stocks to Buy With $300 Right Now
January 29, 2023
From Motley Fool
FDA says it will not regulate CBD and calls on Congress to act
January 26, 2023
Tickers
JAZZ
Tags
JAZZ
From MarketWatch
2 Promising New Growth Stocks to Watch in 2023
January 23, 2023
From Motley Fool
Jazz Pharma, Zymeworks Highlight 84% Overall Survival At 18 Months From Zanidatamab In Esophageal Cancer
January 19, 2023
From Benzinga
From Motley Fool
From Motley Fool
Will Investors Notice Exciting Sign On Jazz Pharmaceuticals's Chart?
January 06, 2023
Tickers
JAZZ
From Benzinga
Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
January 05, 2023
From Benzinga
2 Cannabis Stocks to Buy for the Long Haul
December 31, 2022
From Motley Fool
2 Growth Stocks to Buy Heading Into 2023
December 30, 2022
From Motley Fool
2 Top Biotech Stocks to Buy for the Long Haul
December 25, 2022
From Motley Fool
Better Buy: Moderna vs Axsome
December 22, 2022
From Motley Fool
Tesla, Amazon, Micron, Sintx, Zymeworks: Why These 5 Stocks Are Drawing Investors' Attention Today
December 21, 2022
From Benzinga
Jazz Pharma Opts In, Advances Zanidatamab Partnership With Zymeworks
December 21, 2022
From Benzinga
After Jumping 100%, Is Axsome a Buy Before 2023?
December 16, 2022
From Motley Fool
From Benzinga
What 6 Analyst Ratings Have To Say About Jazz Pharmaceuticals
December 09, 2022
Tickers
JAZZ
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.